Al. Efficacy and safety of a 41. Novartis oncology, the glivec international site. Aboutspecific inhibitor of the bcr-abl tyrosine kinase in chronic glivec: [european] summary of product characteristics [onmyeloidleukemia.
Answers
Answered by
0
from which chapter this is from
Answered by
0
bro what is this..
of which class is this question..
unable to understand..
sorry.. can't help u..
Similar questions